Get the Stockscreener App
213.45
2.19%
-4.7737
Illumina Inc stock is traded at $213.45, with a volume of 925.34K.
It is down -2.19% in the last 24 hours and up +13.55% over the past month.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
See More
Previous Close:
$218.22
Open:
$218.65
24h Volume:
925.34K
Relative Volume:
0.49
Market Cap:
$32.25B
Revenue:
$4.39B
Net Income/Loss:
$853.00M
P/E Ratio:
38.74
EPS:
5.5097
Net Cash Flow:
$556.00M
1W Performance:
+3.04%
1M Performance:
+13.55%
6M Performance:
+71.27%
1Y Performance:
+117.39%
1-Day Range:
$211.64
$219.45
1-Week Range:
$207.13
$221.76
52-Week Range:
$88.00
$231.81
Illumina Inc Stock (ILMN) Company Profile
Name
Illumina Inc
Sector
Industry
Phone
(858) 202-4500
Address
5200 ILLUMINA WAY, SAN DIEGO, CA
Compare ILMN vs TMO, DHR, NTRA, IQV, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
213.57 | 32.95B | 4.39B | 853.00M | 556.00M | 5.5097 |
TMO
Thermo Fisher Scientific Inc
|
606.63 | 226.94B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
206.28 | 145.98B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
327.73 | 47.31B | 2.50B | -226.32M | 71.51M | -1.6412 |
IQV
Iqvia Holdings Inc
|
263.39 | 44.07B | 16.63B | 1.39B | 2.12B | 8.0674 |
A
Agilent Technologies Inc
|
147.80 | 42.53B | 7.23B | 1.41B | 1.09B | 4.979 |
Illumina Inc Stock (ILMN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-12-25 | Downgrade | Daiwa Securities | Outperform → Neutral |
| Jul-11-25 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| Mar-04-25 | Reiterated | Citigroup | Neutral |
| Feb-28-25 | Downgrade | HSBC Securities | Buy → Hold |
| Feb-10-25 | Downgrade | Barclays | Equal Weight → Underweight |
| Feb-07-25 | Downgrade | TD Cowen | Buy → Hold |
| Dec-11-24 | Downgrade | Citigroup | Buy → Neutral |
| Nov-12-24 | Resumed | Morgan Stanley | Equal-Weight |
| Oct-17-24 | Upgrade | HSBC Securities | Hold → Buy |
| Aug-28-24 | Upgrade | Argus | Hold → Buy |
| Aug-16-24 | Upgrade | Daiwa Securities | Neutral → Buy |
| Aug-14-24 | Upgrade | Barclays | Underweight → Equal Weight |
| Aug-14-24 | Upgrade | TD Cowen | Hold → Buy |
| Jul-10-24 | Upgrade | Citigroup | Neutral → Buy |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Jan-16-24 | Downgrade | HSBC Securities | Buy → Hold |
| Jan-04-24 | Downgrade | TD Cowen | Outperform → Market Perform |
| Dec-18-23 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Dec-15-23 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Dec-14-23 | Initiated | Guggenheim | Buy |
| Dec-14-23 | Initiated | Stephens | Overweight |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Dec-12-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Dec-11-23 | Upgrade | Citigroup | Sell → Neutral |
| Nov-10-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Sep-28-23 | Initiated | Bernstein | Underperform |
| Jul-05-23 | Resumed | JP Morgan | Neutral |
| Jan-25-23 | Downgrade | Argus | Buy → Hold |
| Jan-05-23 | Initiated | Scotiabank | Sector Perform |
| Dec-12-22 | Downgrade | Citigroup | Neutral → Sell |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Oct-04-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Sep-28-22 | Upgrade | Evercore ISI | In-line → Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Jul-13-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Jan-18-22 | Upgrade | Stifel | Hold → Buy |
| Jan-11-22 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-07-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Jan-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Jan-06-22 | Resumed | Piper Sandler | Overweight |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-19-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Jun-01-21 | Upgrade | Evercore ISI | Underperform → In-line |
| Mar-31-21 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Mar-31-21 | Upgrade | Canaccord Genuity | Hold → Buy |
| Mar-03-21 | Initiated | Barclays | Underweight |
| Dec-22-20 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-17-20 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-13-20 | Downgrade | Guggenheim | Buy → Neutral |
| Sep-30-20 | Initiated | Atlantic Equities | Overweight |
| Sep-29-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Sep-22-20 | Downgrade | Stifel | Buy → Hold |
| Sep-22-20 | Downgrade | UBS | Buy → Neutral |
| Sep-21-20 | Upgrade | Guggenheim | Neutral → Buy |
| Sep-21-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-09-20 | Initiated | Morgan Stanley | Equal-Weight |
| Aug-07-20 | Downgrade | Evercore ISI | In-line → Underperform |
| Aug-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-07-20 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-24-20 | Downgrade | Citigroup | Buy → Neutral |
| Apr-21-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-20 | Initiated | Wells Fargo | Underweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Jan-02-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-15-19 | Initiated | Stifel | Buy |
| Oct-25-19 | Initiated | Guggenheim | Buy |
View All
Illumina Inc Stock (ILMN) Latest News
The Zacks Analyst Blog Highlights FANUY, ABBNY, KYCCF, NVDA, ISRG, ILMN, NOVT, BOTZ, ROBO, ROBT and IBOT - Zacks Investment Research
Bloom Energy Joins the S&P 500 as The Trade Desk Leaves - TradingView
Illumina: Priced For Perfection It Hasn't Earned Yet (NASDAQ:ILMN) - Seeking Alpha
Bloom Energy, Everpure, Illumina to Join S&P 500 in September Rebalance - marketscreener.com
Illumina Inc. stock gains on S&P 500 re-entry and strong earnings - AD HOC NEWS
Illumina and Everpure to Join S&P 500 in September Rebalancing: What it Means for Investors - Yahoo Finance
Illumina (ILMN) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
Illumina, a "pick company" of deoxyribonucleic acid (DNA) research, succeeded in re-establishing it - 매일경제
Illumina, Inc. (ILMN) Stock Analysis: Navigating Growth Amid Market Volatility - DirectorsTalk Interviews
The Trade Desk to leave S&P 500 as Bloom Energy, Everpure, Illumina join index - Seeking Alpha
Illumina Inc. stock gains on S&P 500 inclusion and collaboration news - AD HOC NEWS
Illumina joins S&P 500 as Bloom Energy, Everpure also added - Financial-News.co.uk
Illumina (ILMN) Stock Looks Priced For Growth More Than Value - Yahoo Finance
Illumina India Wins the Top GCC Award at the 2025 GCC Workplace Awards - Matlabi News
Bloom Energy, Illumina, and Everpure set to join S&P 500 in quarterly rebalance - Investing.com
S&P 500 Index Faces Quarterly Reshuffle: Bloom Energy (BE.US) Stands Out Thanks to AI Computing Power Demand, Illumina (ILMN.US) and Everpure (P.US) Included - Bitget
Illumina director Keith Meister sells $57.2 million in stock By Investing.com - Investing.com South Africa
Could Illumina’s Novacyt Collaboration Framework Quietly Reshape Its Clinical Sequencing Narrative (ILMN)? - Yahoo Finance
Bloom Energy, Illumina, and Everpure Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600 - Investing News Network
Illumina director Keith Meister sells $57.2 million in stock - Investing.com
Bloom Energy, Illumina, Everpure to Join S&P 500 in September Rebalance - finance.biggo.com
Bloom Energy, Illumina, Everpure To Join S&P 500 - marketscreener.com
Director-linked funds sell Illumina (NASDAQ: ILMN) shares without preset plan - Stock Titan
Bloom Energy, Illumina and Everpure set to join S&P 500 before Sept. 21 open - Briefs Finance
Bloom Energy surges on inclusion to S&P 500; Illumina, Everpure also added (BE:NYSE) - Seeking Alpha
Bloom Energy, Illumina, Everpure to Join S&P 500 This Month - Bloomberg.com
Illumina’s S&P 500 Return Adds $704 Million After Hours - TechStock²
Illumina Inc. stock underperforms Friday when compared to competitors - marketwatch.com
Illumina Inc (ILMN) Stock Up 3.9% but GF Value Says Overvalued -- GF Score: 71/100 - GuruFocus
The Market Just Told You Which Layer Of AI Biology It Is Paying For - Investing News Network
Illumina Inc. stock outperforms competitors on strong trading day - marketwatch.com
Beyond the Human Genome Project: What’s next for genomics? - Illumina
Pillar Biosciences Adds Illumina and ORI Capital Executives to Board - citybiz
Illumina Inc. stock falls despite strong rebound from mid-2025 lows - AD HOC NEWS
Illumina Inc (ILMN) Shares Fall 3.0% -- GF Value Says Still Over - GuruFocus
Illumina Inc. stock underperforms Tuesday when compared to competitors - marketwatch.com
Illumina Inc. stock gains on fresh collaboration and solid quarterly figures - AD HOC NEWS
Illumina StrataMap Spatial Transcriptome: Library quantification and sequencing - Illumina
Illumina Inc (ILMN) Shares Fall 5.3% -- What GF Score of 71 Tells Investors - GuruFocus
Illumina (ILMN) director’s funds unload stock over 3 days - Stock Titan
7,091 Shares in Illumina, Inc. $ILMN Acquired by Daiichi Life Insurance Co. Ltd. - InsuranceNewsNet
Illumina (ILMN) Replaces Prior Deal With $1 Billion Revolving Credit Facility - Yahoo Finance
Illumina, Inc. (ILMN) Stock Analysis: Navigating the Genomics Giant’s 9.40% Revenue Growth amid Volatility - DirectorsTalk Interviews
Illumina, Inc. Post Earnings: Buy On A Pullback (NASDAQ:ILMN) - Seeking Alpha
Illumina director Keith Meister sells $145.5m in shares By Investing.com - Investing.com India
Insider Selling: Illumina (NASDAQ:ILMN) Director Sells 95,000 Shares of Stock - MarketBeat
Illumina (NASDAQ: ILMN) director's funds sell shares across three days - Stock Titan
Illumina stock hits fresh multi-year high as institutional buyers step in - Ad-hoc-news.de
Illumina (NASDAQ: ILMN) backer plans new multi-million-dollar stock sale - Stock Titan
OVERSEA CHINESE BANKING Corp Ltd Takes $6.71 Million Position in Illumina, Inc. $ILMN - MarketBeat
OVERSEA CHINESE BANKING Corp Ltd Invests $44.60 Million in Illumina, Inc. $ILMN - MarketBeat
Illumina Inc Stock (ILMN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.87%
0.30%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):